On this page
Monoclate, Monoclate-P
Antihemophilic Factor (Human)
351(a) Standalone BLA
Overview
Source: Purple BookProprietary name
Monoclate, Monoclate-P
Proper name
Antihemophilic Factor (Human)
Licence type
351(a)
BLA number
103953
Applicant
CSL Behring LLC
Center
CBER
Presentations
4
First licensure
—
Presentations
Source: Purple Book| Strength | Dosage form | Route | Presentation | Status | Licensed |
|---|---|---|---|---|---|
| 1000IU | For Injection | Intravenous | Vial | Disc | May 14, 2003 |
| 1500IU | For Injection | Intravenous | Vial | Disc | March 4, 2004 |
| 250IU | For Injection | Intravenous | Vial | Disc | May 14, 2003 |
| 500IU | For Injection | Intravenous | Vial | Disc | May 14, 2003 |
Sources for this page
| Purple Book | FDA | Licence type, presentations, reference product, exclusivity |